Loading clinical trials...
Loading clinical trials...
The Impact of Dry Eye Syndrome on Novel Metrics of Low Contrast Vision Before and After Therapeutic Meibomian Gland Expression
Conditions
Interventions
Meibomian gland (MG) expression
Locations
1
United States
University of the Incarnate Word Rosenberg School of Optometry
San Antonio, Texas, United States
Start Date
March 1, 2023
Primary Completion Date
June 8, 2023
Completion Date
June 8, 2023
Last Updated
June 26, 2023
NCT06220474
NCT06542276
NCT06064071
NCT03652337
NCT05577910
NCT07224529
Lead Sponsor
University of the Incarnate Word
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions